PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 210 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $554,000 | +12.8% | 23,180 | +26.6% | 0.00% | 0.0% |
| Q3 2019 | $491,000 | -1.2% | 18,310 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $497,000 | +13.5% | 18,310 | +45.2% | 0.00% | +50.0% |
| Q1 2019 | $438,000 | -59.1% | 12,610 | -55.5% | 0.00% | -66.7% |
| Q2 2018 | $1,070,000 | +14.4% | 28,341 | -1.0% | 0.01% | +20.0% |
| Q1 2018 | $935,000 | +310.1% | 28,631 | +510.3% | 0.01% | +400.0% |
| Q4 2017 | $228,000 | -40.9% | 4,691 | -34.4% | 0.00% | -50.0% |
| Q3 2017 | $386,000 | +67.8% | 7,150 | -26.6% | 0.00% | 0.0% |
| Q2 2016 | $230,000 | -35.4% | 9,745 | -29.0% | 0.00% | -50.0% |
| Q1 2014 | $356,000 | – | 13,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 170,129 | $3,321,000 | 9.18% |
| CADIAN CAPITAL MANAGEMENT, LP | 6,462,605 | $126,150,000 | 5.87% |
| Fernwood Investment Management, LLC | 340,263 | $6,642,000 | 4.28% |
| Tamarack Advisers, LP | 400,000 | $7,808,000 | 3.18% |
| Grace Capital | 279,209 | $5,456,000 | 2.53% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,582,129 | $30,883,000 | 2.37% |
| Foresite Capital Management IV, LLC | 250,000 | $4,880,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 823,607 | $16,077,000 | 2.18% |
| HARVEY CAPITAL MANAGEMENT INC | 164,672 | $3,214,000 | 1.71% |
| WISCONSIN CAPITAL MANAGEMENT LLC | 68,549 | $1,338,000 | 1.42% |